Table 1.

Adjusted baseline characteristics^*

	Troponin T Group
	Group 1 (<0.003 μg/L) (n=3258)	Group 2 (0.003 μg/L to ≤0.005 μg/L) (n=2500)	Group 3 (0.006 μg/L to ≤0.008 μg/L) (n=1971)	Group 4 (0.009 μg/L to ≤0.013 μg/L) (n=1254)	Group 5 ≥0.014 μg/L (n=715)	P
Demographic
• Age, yrs	60.7	62.4	63.6	64.9	65.2	<0.0001
• Race, % white	78.2	80.7	78.2	76.6	70.4	<0.0001
• Gender, % male	20.9	37.7	52.8	63.6	73.7	<0.0001
• BMI, kg/m2	27.8	28.6	29.4	30.0	30.4	<0.0001
Medical History
• Hypertension, %	38.7	42.	48.2	53.6	61.9	<0.0001
• Current smoking, %	22.0	13.0	10.0	10.0	11.2	<0.0001
• Former smoking, %	40.5	42.2	42.6	43.8	43.7	0.297
• Diabetes mellitus, %	9.8	12.4	17.3	21.1	35.4	<0.0001
• Systolic blood pressure, mm Hg	125.2	126.6	128.1	130.5	130.8	<0.0001
• Diastolic blood pressure, mm Hg	70.7	71.1	71.5	71.9	70.9	0.0088
Laboratory Data
• Total cholesterol, mg/dL	203.6	202.1	201.1	200.6	197.3	0.0027
• HDL-C, mg/dL	51.8	51.0	50.2	49.6	48.7	<0.0001
• Triglycerides, mg/dL	137.8	139.1	142.8	149.5	157.1	0.0002
• eGFR, mL/min†	86.6	85.6	84.0	82.5	76.8	<0.0001
• Mean hs-CRP, mg/L‡	4.2	4.2	4.3	4.5	6.9	<0.0001
• Mean NT-proBNP, pg/mL§	70.1	92.4	112.4	149.9	530.7	<0.0001
Medications
• Aspirin, %	53.9	53.8	53.3	54.9	57.9	0.310
• Antihypertensives, %	27.8	30.8	37.0	41.3	50.6	<0.0001
• Statins, %	8.8	8.2	7.9	9.9	10.4	0.143
LVH, %||	1.8	2.0	3.3	4.2	8.2	<0.0001

^*Adjusted for age, gender, and race

^†eGFR calculated with the Chronic Kidney Disease Epidemiology Collaboration formula

^‡Unadjusted median hs-CRP (mg/L): Group 1, 2.68; Group 2, 2.30; Group 3, 2.14; Group 4, 2.10; Group 5, 2.74; p<0.0001

^§Unadjusted median NT-proBNP (pg/mL): Group 1, 59.00; Group 2, 61.65; Group 3, 61.60 Group 4, 71.30; Group 5, 98.00; p<0.0001

^||LVH calculated by electrocardiographic Cornell Criteria